SCHEMBL16174341

SCHEMBL16174341

CC(CO)CCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046450 0.92
SCHEMBL541637 0.86 TSHR (0.61)
SCHEMBL12532716 0.83
SCHEMBL21831585 0.83 TSHR (0.58)
SCHEMBL26245 0.83 LMNA (0.53)
SCHEMBL542077 0.83 TSHR (0.58)
SCHEMBL29629355 0.83 TSHR (0.58)
SCHEMBL21409909 0.83 TSHR (0.58)
SCHEMBL22129601 0.83 TSHR (0.58)
SCHEMBL9618070 0.83 TSHR (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118127663-B Method for preparing flame-retardant DTY polyester yarns by regenerating polyester fibers 安徽保尔盈新材料科技有限公司 2024-07-23 CN disclosed
CN-118127663-A Method for preparing flame-retardant DTY polyester yarns by regenerating polyester fibers 安徽保尔盈新材料科技有限公司 2024-06-04 CN disclosed
EP-3571208-B1 IMMUNOPROTEASOME INHIBITORS PRINCIPIA BIOPHARMA INC (US) 2021-03-10 EP disclosed
WO-2018136401-A1 IMMUNOPROTEASOME INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2018-07-26 WO disclosed
US-9428448-B2 Compounds and methods of treating obesity YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2016-08-30 US disclosed
US-20140309273-A1 COMPOUNDS AND METHODS OF TREATING OBESITY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2014-10-16 US disclosed